US turns to Gilead’s COVID-19 drug to help counter omicron

With other COVID-19 treatments ineffective against the variant or in short supply, the FDA is expanding its approval of Veklury to include outpatient use.

Show CommentsClose Comments

Leave a comment

%d bloggers like this: